{"id":48548,"date":"2022-09-19T18:01:37","date_gmt":"2022-09-19T16:01:37","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/bioqual-presents-financial-results-for-fiscal-year-2022\/"},"modified":"2022-09-19T18:01:37","modified_gmt":"2022-09-19T16:01:37","slug":"bioqual-presents-financial-results-for-fiscal-year-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/bioqual-presents-financial-results-for-fiscal-year-2022\/","title":{"rendered":"BIOQUAL Presents Financial Results for Fiscal Year 2022"},"content":{"rendered":"
\n

ROCKVILLE, Md.–(BUSINESS WIRE)–BIOQUAL, Inc. (OTC-Pink:BIOQ) (www.bioqual.com<\/a>)<\/b>:\n<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n2022<\/span>\n<\/p>\n<\/td>\n

<\/td>\n\n

\n2021<\/span>\n<\/p>\n<\/td>\n<\/tr>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n

\nRevenue\n<\/p>\n<\/td>\n

<\/td>\n\n

\n$\n<\/p>\n<\/td>\n

\n

\n66,150,373\n<\/p>\n<\/td>\n

<\/td>\n\n

\n$\n<\/p>\n<\/td>\n

\n

\n57,683,502\n<\/p>\n<\/td>\n<\/tr>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n

\nIncome Before Income Tax\n<\/p>\n<\/td>\n

<\/td>\n\n

\n$\n<\/p>\n<\/td>\n

\n

\n6,576,784\n<\/p>\n<\/td>\n

<\/td>\n\n

\n$\n<\/p>\n<\/td>\n

\n

\n8,616,025\n<\/p>\n<\/td>\n<\/tr>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n

\nNet Income\n<\/p>\n<\/td>\n

<\/td>\n\n

\n$\n<\/p>\n<\/td>\n

\n

\n5,260,569\n<\/p>\n<\/td>\n

<\/td>\n\n

\n$\n<\/p>\n<\/td>\n

\n

\n6,326,825\n<\/p>\n<\/td>\n<\/tr>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n

\nBasic Earnings per Share of Common Stock\n<\/p>\n<\/td>\n

<\/td>\n\n

\n$\n<\/p>\n<\/td>\n

\n

\n5.88\n<\/p>\n<\/td>\n

<\/td>\n\n

\n$\n<\/p>\n<\/td>\n

\n

\n7.08\n<\/p>\n<\/td>\n<\/tr>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n

\nDiluted Earnings per Share of Common Stock\n<\/p>\n<\/td>\n

<\/td>\n\n

\n$\n<\/p>\n<\/td>\n

\n

\n5.88\n<\/p>\n<\/td>\n

<\/td>\n\n

\n$\n<\/p>\n<\/td>\n

\n

\n7.08\n<\/p>\n<\/td>\n<\/tr>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n

\nWeighted Average Number of Shares Outstanding For Basic Earnings Per Share\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n894,416\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n894,054\n<\/p>\n<\/td>\n<\/tr>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n

\nWeighted Average Number of Shares Outstanding For Diluted Earnings Per Share\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n894,423\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n894,054\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

\nStatements herein that are not descriptions of historical facts are forward-looking and subject to risks and uncertainties. The forward-looking statements are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond the Company\u2019s control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements, including risks relating to the ability to continue to extend current government contracts; the Company\u2019s ability to obtain new government or commercial contracts; continued demand for the use of animal models in scientific research; the Company\u2019s ability to obtain sufficient numbers of animal models; the availability of adequate numbers of employees; the Company\u2019s ability to perform under its contracts in accordance with the requirements of the contracts; the actual costs incurred in performing the Company\u2019s contracts and its ability to manage its costs, including its capital expenditures; dependence on third parties; future capital needs; the ability to fund its capital needs through the use of its cash on hand and line of credit; and the future availability and cost of financing\/capital sources to the Company.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMark G. Lewis, Ph.D., CEO (240-404-7654)\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

ROCKVILLE, Md.–(BUSINESS WIRE)–BIOQUAL, Inc. (OTC-Pink:BIOQ) (www.bioqual.com): \u00a0 2022 2021 \u00a0 Revenue $ 66,150,373 $ 57,683,502 \u00a0 Income Before Income Tax $ 6,576,784 $ 8,616,025 \u00a0 Net Income $ 5,260,569 $ 6,326,825 \u00a0 Basic Earnings per Share of Common Stock $ 5.88 $ 7.08 \u00a0 Diluted Earnings per Share of Common Stock $ 5.88 $ 7.08 … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48548","6":"format-standard","7":"category-industry"},"yoast_head":"\nBIOQUAL Presents Financial Results for Fiscal Year 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/bioqual-presents-financial-results-for-fiscal-year-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BIOQUAL Presents Financial Results for Fiscal Year 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"ROCKVILLE, Md.–(BUSINESS WIRE)–BIOQUAL, Inc. (OTC-Pink:BIOQ) (www.bioqual.com): \u00a0 2022 2021 \u00a0 Revenue $ 66,150,373 $ 57,683,502 \u00a0 Income Before Income Tax $ 6,576,784 $ 8,616,025 \u00a0 Net Income $ 5,260,569 $ 6,326,825 \u00a0 Basic Earnings per Share of Common Stock $ 5.88 $ 7.08 \u00a0 Diluted Earnings per Share of Common Stock $ 5.88 $ 7.08 ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/bioqual-presents-financial-results-for-fiscal-year-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-19T16:01:37+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bioqual-presents-financial-results-for-fiscal-year-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bioqual-presents-financial-results-for-fiscal-year-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"BIOQUAL Presents Financial Results for Fiscal Year 2022\",\"datePublished\":\"2022-09-19T16:01:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bioqual-presents-financial-results-for-fiscal-year-2022\\\/\"},\"wordCount\":275,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bioqual-presents-financial-results-for-fiscal-year-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bioqual-presents-financial-results-for-fiscal-year-2022\\\/\",\"name\":\"BIOQUAL Presents Financial Results for Fiscal Year 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2022-09-19T16:01:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bioqual-presents-financial-results-for-fiscal-year-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bioqual-presents-financial-results-for-fiscal-year-2022\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bioqual-presents-financial-results-for-fiscal-year-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BIOQUAL Presents Financial Results for Fiscal Year 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BIOQUAL Presents Financial Results for Fiscal Year 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/bioqual-presents-financial-results-for-fiscal-year-2022\/","og_locale":"en_US","og_type":"article","og_title":"BIOQUAL Presents Financial Results for Fiscal Year 2022 - Pharma Trend","og_description":"ROCKVILLE, Md.–(BUSINESS WIRE)–BIOQUAL, Inc. (OTC-Pink:BIOQ) (www.bioqual.com): \u00a0 2022 2021 \u00a0 Revenue $ 66,150,373 $ 57,683,502 \u00a0 Income Before Income Tax $ 6,576,784 $ 8,616,025 \u00a0 Net Income $ 5,260,569 $ 6,326,825 \u00a0 Basic Earnings per Share of Common Stock $ 5.88 $ 7.08 \u00a0 Diluted Earnings per Share of Common Stock $ 5.88 $ 7.08 ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/bioqual-presents-financial-results-for-fiscal-year-2022\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-19T16:01:37+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/bioqual-presents-financial-results-for-fiscal-year-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/bioqual-presents-financial-results-for-fiscal-year-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"BIOQUAL Presents Financial Results for Fiscal Year 2022","datePublished":"2022-09-19T16:01:37+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/bioqual-presents-financial-results-for-fiscal-year-2022\/"},"wordCount":275,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/bioqual-presents-financial-results-for-fiscal-year-2022\/","url":"https:\/\/pharma-trend.com\/en\/bioqual-presents-financial-results-for-fiscal-year-2022\/","name":"BIOQUAL Presents Financial Results for Fiscal Year 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2022-09-19T16:01:37+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/bioqual-presents-financial-results-for-fiscal-year-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/bioqual-presents-financial-results-for-fiscal-year-2022\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/bioqual-presents-financial-results-for-fiscal-year-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"BIOQUAL Presents Financial Results for Fiscal Year 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48548","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48548"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48548\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48548"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48548"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48548"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}